Hyperammonemia not caused by liver failure
Mar. 04, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
This signaling pathway, mediated by nitric oxide, can protect developing neurons against alcohol toxicity. Nitric oxide (NO) is produced by neuronal nitric oxide synthase (nNOS). Increased levels of NO activate soluble guanylyl cyclase (sGC), which synthesizes cyclic GMP (cGMP). This cyclic nucleotide subsequently activates cyclic GMP-dependent protein kinases (PKG). The kinases phosphorylate downstream targets. One of these downstream targets is the transcription factor, NF-kappa B, which presumably promotes neuronal survival against alcohol by enhancing transcription of neuroprotective genes. Genetic differences in the expression of this pathway can produce marked differences in vulnerability to alcohol teratogenesis in mice and may underlie differences in outcome among humans exposed to alcohol in utero. (Contributed by Dr. Daniel Bonthius.)